Skip to main navigation
Skip to search
Skip to main content
University of Ghana Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Corneal collagen cross-linking for treating keratoconus
Evripidis Sykakis
, Rushmia Karim
, Jennifer R. Evans
, Catey Bunce
, Kwesi N. Amissah-Arthur
, Showrob Patwary
, Peter J. Mcdonnell
, Samer Hamada
Queen Victoria Hospital NHS Foundation Trust
Moorfields Eye Hospital NHS Foundation Trust
London School of Hygiene & Tropical Medicine
Sandwell and West Birmingham Hospitals NHS Trust
Research output
:
Contribution to journal
›
Review article
›
peer-review
41
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Corneal collagen cross-linking for treating keratoconus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Adverse Event
80%
Anterior Chamber of Eyeball
40%
Clinical Significance
20%
Clinical Trial
20%
Cornea Edema
40%
Corneal Neovascularization
20%
Corneal Topography
40%
Cross-Link
100%
Deterioration
20%
Disease
40%
Health Care Cost
20%
High Risk Population
20%
Keratoconus
100%
Masking
20%
Outcome Assessment
20%
Quality of Life
40%
Randomized Controlled Trial
100%
Recurrent Corneal Erosion
20%
Riboflavin
60%
Visual Acuity
60%
Nursing and Health Professions
Adverse Event
66%
CINAHL
16%
Cochrane Library
16%
Confidence Interval
100%
Cornea Curvature
16%
Cornea Edema
33%
Cornea Erosion
16%
Cornea Neovascularization
16%
Cornea Thickness
16%
Corneal Topography
33%
Deterioration
16%
Disease
33%
High Risk Population
16%
Inflammation
33%
Keratoconus
100%
Masking
16%
Outcome Assessment
16%
Quality of Life
33%
Riboflavin
50%
Visual Acuity
50%
World Health Organization
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
80%
Clinical Trial
20%
Cornea Edema
40%
Cornea Erosion
20%
Cornea Neovascularization
20%
Deterioration
20%
Disease
40%
Inflammation
40%
Keratoconus
100%
Randomized Controlled Trial
100%
Riboflavin
60%
Agricultural and Biological Sciences
Adverse Effects
50%
Americans
16%
Confidence Interval
100%
Publications
16%
Quality of Life
33%
Riboflavin
50%
Risk Groups
16%
Selection Criterion
16%
World Health Organization
16%